We identified a strong association (P ¼ 5.36 Â 10 À17 ) between rs492602 in FUT2 and plasma vitamin B 12 levels in a genomewide scan (n ¼ 1,658) and an independent replication sample (n ¼ 1,059) from the Nurses' Health Study. Women homozygous for the rs492602[G] allele had higher B 12 levels. This allele is in strong linkage disequilibrium with the FUT2 nonsecretor variant encoding W143X, suggesting a plausible mechanism for altered B 12 absorption and plasma levels.
We identified a strong association (P ¼ 5.36 Â 10 À17 ) between rs492602 in FUT2 and plasma vitamin B 12 levels in a genomewide scan (n ¼ 1,658) and an independent replication sample (n ¼ 1,059) from the Nurses' Health Study. Women homozygous for the rs492602[G] allele had higher B 12 levels. This allele is in strong linkage disequilibrium with the FUT2 nonsecretor variant encoding W143X, suggesting a plausible mechanism for altered B 12 absorption and plasma levels. 12 is a modifiable quantitative trait associated with certain diseases 1 . Vitamin B 12 found in meat (such as liver, shellfish, fish, poultry and eggs) and milk products 2 is composed of corrin and cobalt rings and is necessary for the formation of red blood cells, DNA synthesis during cell division and maintenance of the myelin nerve sheath. Deficiency in vitamin B 12 , clinically associated with pernicious anemia, cardiovascular disease, cancer and neurodegenerative disorders is often related to poor intestinal B 12 absorption 2 rather than direct dietary deficiency (the recommended adult intake for vitamin B 12 is 2.4 mg/day). In the Nurses' Health Study (NHS), we previously observed that women in the lowest quartile of plasma vitamin B 12 levels had marginally worse cognitive performance (based on a global score averaging six cognitive tests) than women in the highest quartile of plasma vitamin B 12 and that combined folate and vitamin B 12 deficiency was associated with the lowest cognitive performance 3 .
Plasma level of vitamin B
Epidemiologic studies provide evidence for the association of genes and metabolites in the B-vitamin-mediated plasma one-carbon metabolic pathway with chronic diseases [2] [3] [4] . Rare high-penetrance mutations in genes in this pathway affect the ability to digest, absorb 5 and utilize vitamin B 12 (ref. 2). However, common genetic variants in candidate genes have not been consistently associated with plasma vitamin B 12 levels. Therefore, we conducted a genome-wide association study (GWAS) to identify loci that influence plasma vitamin B 12 levels in 1,658 women genotyped with the HumanHap500 as part of the Cancer Genetic Markers of Susceptibility project (CGEMS; Supplementary Methods online). Participants were of self-reported European ancestry 6 . Detailed methods have been previously reported, including quality control assessment of genotypes with sample completion and SNP call rates, concordance rate, deviation from HardyWeinberg proportions in control DNA and final sample selection for association analysis of the NHS CGEMS population 6 .
We tested association between each of the 528,134 SNP markers that passed quality control filters and log-transformed plasma vitamin B 12 using linear regression, adjusted for age, total methyl intake (defined as total folate, dietary methionine and alcohol intake) and assay batch. We did not find any evidence for systematic bias in the distribution of P values for analyses with and without further adjustment for residual population structure using the top four principal components of genetic variation ( Supplementary Fig. 1 online), compatible with no confounding of SNP-metabolite associations due to population stratification. In the initial GWAS, the SNPs on chromosome 19p13.3 accounted for the excess of P values o10 -7 ( Supplementary Fig. 1 , quantilequantile plot). The strongest association with plasma vitamin B 12 was for rs602662 (P trend ¼ 6.54 Â 10 À10 ; Fig. 1 12 and rs602662 using Taqman allelic discrimination assays in 1,059 women from two nested case-control studies drawn from the same cohort (Table 1 and Supplementary Table 2 online) with P trend ¼ 1.13 Â 10 À06 . The joint analysis of the CGEMS scan data and the replication dataset supports the association of rs602662 with plasma vitamin B 12 (P trend ¼ 3.51 Â 10 À15 ). We obtained similar results using untransformed plasma vitamin B 12 values. A similar association was observed using the nonparametric Kruskal-Wallis test (joint analysis KruskalWallis P ¼ 1.48 Â 10 À21 ). Plasma vitamin B 12 has an inverse correlation in this dataset with plasma homocysteine, an integrated marker of the one-carbon metabolism pathway (Spearman correlation coefficient -0.26, P o 0.0001). FUT2 rs602662 also has a modest association with plasma homocysteine (P trend ¼ 0.0085 in the GWAS data and P trend ¼ 0.0081 in the replication data). The pattern of mean log-transformed plasma vitamin B 12 levels by rs602662 genotype suggests a dominant genetic effect, with lower B 12 levels among variant carriers (test comparing mean log-transformed vitamin B 12 levels between variant carriers and noncarriers P ¼ 1.35 Â 10 À39 ).
The SNP rs602662 is in strong linkage disequilibrium (D¢ ¼ 1, r 2 ¼ 0.76) with the FUT2 nonsense SNP encoding W143X (rs601338; Fig. 1) . We imputed the nonsense SNP in the initial GWAS samples using the observed chromosome 19 genotyping data augmented by data from the densely genotyped CEPH European HapMap samples and found that it was strongly associated with plasma vitamin B 12 levels (P trend ¼ 4.11 Â 10 À10 ; Fig. 1 and Table 1 ). As the nonsense SNP rs601338 could not be genotyped by Taqman because of a neighboring SNP (rs1800459) located one nucleotide upstream, we genotyped a proxy SNP, rs492602 (which is in perfect LD with rs601338 in HapMap data; Supplementary Table 1 and Supplementary Fig. 3) , in both the initial GWAS and the replication dataset. The association between rs492602 and plasma vitamin B 12 was stronger than the association for rs602662 and plasma vitamin B 12 (Table 1, rs492602 joint P trend ¼ 5.36 Â 10 -17 ; joint dominant model P ¼ 8.26 Â 10 -45 ). The rs492602 SNP explains 2.5% of the variance in logtransformed plasma vitamin B 12 levels using the log-additive genetic model and 3.5% of variance using the dominant genetic model. Fucosylated carbohydrate structures are involved in a range of biological processes 7, 8 , including tissue development, angiogenesis, fertilization, cell adhesion, inflammation and tumor metastasis. The classic human secretor locus FUT2 encodes a,1,2-fucosyltransferase, which regulates expression of the Lewis ABO(H) histo-blood group antigens on the surface of epithelial cells and in body fluids and determines the secretion status of the ABO antigens 7 . Secretor status of this polymorphic protein was used by Mohr to provide the first autosomal linkage in humans between secretor factor and the Lutheran blood group; subsequently, secretor linkage was established with APOE and the locus associated with myotonic dystrophy 7 . The family of a,1,2-fucosyltransferases catalyze the addition of fucose in a,1,2-linkage to the galactose of type 1(Gal-b(1-3)-GlcNAc-R) and type 2 (Gal-b(1-4)-GlcNAc-R) disaccharide to form H type 1 and H type 2 antigens 7 , respectively. In the highly polymorphic FUT2 gene 7 , three SNPs, rs602662, rs492602 and rs601338 (W143X; nucleotide position 428), are in strong LD; we note that the variant encoding W143X is a nonsense mutation 7 and plausibly the causal variant for the association with plasma B 12 levels. The variant encoding 143X is characteristic for the nonsecretor allele in Europeans and has an allele frequency of 0.46 in populations of European ancestry 7 . In Europeans, Africans and Iranians, the FUT2 nonsense mutation encoding W143X is the primary nonsecretor allele, with a frequency of approximately 50%. In contrast, in Asian populations, the FUT2 missense mutation encoding I129F (nucleotide position 385) is the primary nonsecretor allele 8 . In non-Asian populations, nonsecretors are frequently homozygous for the FUT2 W143X polymorphism, resulting in an inactive FUT2. Individuals homozygous for the FUT2 nonsecretor genotype seem to be resistant to infection with norovirus 9 , suggesting that individuals homozygous for nonsecretor status may be unable to mediate host-microbe interactions 9 .
Absorption of B 12 requires the secretion of the glycoprotein intrinsic factor from the gastric cells, binding of intrinsic factor to vitamin B 12 and a functional gastrointestinal absorption system 2 . The H-antigen synthesized by FUT2, Lewis ABO antigens and FUT2 genotypes have all been reported to mediate Helicobacter pylori attachment to human gastric mucosa 10 . Atrophic gastritis is a consequence of H. pylori infection 11 and leads to reduced secretion of intrinsic factor 12, 14 . The FUT2 secretor status has been associated with both H. pylori infection and gastritis 10 ; individuals with vitamin B 12 malabsorption and low levels of serum vitamin B 12 have higher seroprevalence of H. pylori infection 10 . These data suggest a potential mechanism by which vitamin B 12 absorption 12-15 may be reduced in carriers of the secretor genotype owing to the sequelae of susceptibility to H. pylori infection compared to individuals with the nonsecretor genotype.
In summary, among generally well-nourished women, we found that common variation in the FUT2 secretor gene is associated with plasma vitamin B 12 at high levels of statistical confidence. Although the participants included in these analyses are a selected subset of women who had plasma vitamin B 12 levels measured, numerous demographic and lifestyle factors are comparable between this sample and the overall NHS cohort. Insights gained from the study of plasma vitamin B 12 are likely to have implications for the study of complex diseases such as cognitive decline, cancer and cardiovascular disease. Further study is required to investigate the biological basis of our reported association findings.
